Digital Therapeutics market Trends, Analysis by 2035

The rise in the demand for convenient treatment options for patients across all age groups, specifically post COVID 19, has tremendously increased the adoption of digital therapeutics.

This led to the integration of digital therapeutics solutions into routine healthcare and has helped in overcoming geographical barriers by enabling patients to access healthcare in quick, effective and cost-efficient manner. Several industry / non-industry players have shown a keen interest in digital therapeutics; with increasing adoption of such solutions, we expect the domain to present numerous lucrative investment opportunities.

The financial opportunity within the digital therapeutics market has been analyzed across the following segments:
 Type of Solution
 Standalone Software Application
 Combination Offerings of Software Application + Device
 Combination Offerings of Software Application + AI Support
 Combination Offerings of Software Application + Personal Coach
 Combination Offerings of Software Application + Device + AI Support
 Combination Offerings of Software Application + Device + Personal Coach
 Others

 Type of Therapy
 Curative Solution
 Preventive Solution

 Therapeutic Area
 Cardiovascular Disorders
 Mental Health Problems
 Metabolic Disorders
 Neurological Disorders
 Pain Management
 Respiratory Disorders
 Sleep Disorders
 Substance Use Disorders
 Others

 Key Geographical Regions
 North America
 Europe
 Asia-Pacific and Rest of the World

The Investor Series: Opportunities in Digital Therapeutics Market, detailed profiles of the key public ventures engaged in the development of digital therapeutics solutions; each profile features a brief overview of the company, details on its management team, insights from its balance sheet (if available), details on its product / service portfolio, recent developments and key financial details (including company investment highlights, company fundamental and company technical analysis).

Table of Contents

Excel Deliverables
1. Innovators and Product Dataset

2. Funding and Investment Analysis

3. Fundamental and Technical Financial Analysis

4. Business Risk Analysis

5. Market Forecast and Opportunity Analysis

6. Return on Investment

PowerPoint Deliverable
1. Context

2. Project Approach

3. Project Objective

4. Executive Summary

Section I: Need for Digital Therapeutics and Innovators Landscape
5. The Digital Health Market

6. Digital Therapeutics: Innovator Landscape

7. Digital Therapeutics: Product Landscape and Company Health Indexing

8. Value Proposition Analysis

9. Company Competitiveness Analysis

Section II: Analysis of Investments
10. Funding and Investment Analysis

Section III: Financial Analysis and Assessment of Business Risks
11. Financial Analysis of Public Ventures

12. Company Profiles of Public Ventures

13. Business Risk Analysis

Section IV: Market Forecast and Opportunity Analysis
14. Market Forecast

Section V: Analysis of Returns on Investment and Key Acquisition Targets
15. Analysis of Return on Investment

16. Key Acquisition Targets

17. Conclusion

18. Appendices

To view more details on this report, click on the link
https://www.rootsanalysis.com/....reports/opportunitie

You may also be interested in the following titles:
Conjugation and Labeling Services Market

Bispecific Antibodies Market
Viral Clearance and Testing Services Market

Genotoxicity Testing and Mutagenicity Testing Services Market




About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com

#digitalhealth #prescriptiondigitaltherapeutics #digitalhealthcompanies #marketresearch #marketinsights

Long Acting Drugs market Size, Share, Trends by 2035


The conventional treatment options available for several diseases are known to be associated with several challenges, such as patient non-compliance, non-adherence to medication and multiple dosing regimen.

In order to circumvent the abovementioned challenges, the demand for long-acting drugs is increasing. The development and manufacturing of these novel pharmacological modalities require advanced long-acting drug delivery technologies and dedicated expertise available with service providers.

The financial opportunity within the long acting drug delivery technologies and services market has been analyzed across the following segments:
 Principle
 Manipulation of drug release from delivery systems
 Manipulation of in vivo clearance

 Strategy
 Chemical Modification
 Micro-encapsulation
 Long-Acting Hydrogels
 Long-Acting Implants
 Long-Acting Microneedles
 Multivesicular Liposomes
 Nanocrystal Suspensions
 Protein Fusion

 Compatible Dosage Form
 Injectables
 Implantables
 Oral Dosage Forms
 Topical / Transdermal Dosage Forms
 Vaginal Dosage Forms
 Other Dosage Forms

 Type of Molecules Delivered
 Small Molecules
 Biologics
 Other Molecules

 Type of Material Used
 Polymer based
 Non-polymer based

 Key Geographical Regions
 North America
 Europe
 Asia-Pacific
 Middle East and North Africa


The Long-Acting Drug Delivery Market, 2023-2035 report features the following companies, which we identified to be key players in this domain:
 Adare Pharma Solutions
 AMW
 Bostal Drug Delivery
 Creative Biolabs
 ForDoz Pharma
 Innocore Pharmaceuticals
 Integral BioSystems
 LATITUDE Pharmaceuticals
 Navin Saxena Research and Technology Centre (NSRT)
 Samyang Biopharm

Table of Contents

1. Preface

2. Executive Summary

3. Introduction

4. Technology Landscape

5. Service Providers Landscape

6. Technology Competitiveness Analysis

7. Company Competitiveness Analysis

8. Company Profiles

9. Partnerships and Collaborations

10. Publication Analysis

11. Patent Analysis

12. Grant Analysis

13. Market Forecast and Opportunity Analysis

14. Conclusion

15. Interview Transcripts

16. Appendix 1: Tabulated Data

17. Appendix 2: List of Companies and Organizations

To view more details on this report, click on the link
https://www.rootsanalysis.com/....reports/long-acting-

You may also be interested in the following titles:
Conjugation and Labeling Services Market

Bispecific Antibodies Market
4D Bioprinting Market

Deep Learning in Drug Discovery and Deep Learning in Diagnostics Market



About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com

Manufacturing execution systems market Trends, Analysis by 2035

Rising complexities related to huge data volumes being generated in the healthcare sector, along with the need for visibility, control and synchronization in production processes, has prompted players in the healthcare market to integrate manufacturing execution systems

Driven by the ongoing innovation in the healthcare industry, as well as the rise in the demand for automated solutions in order to connect, monitor and control the complex production process, the MES providers market for the healthcare sector is likely to witness positive growth over the coming years. It is worth highlighting that, players are integrating advanced technologies, including internet of thing (IoT) and artificial intelligence (AI), in order to collect and analyze large volumes of data from various sources, as well as to produce value in the form of insights, predictions and actions.

The financial opportunity within the manufacturing execution system providers in healthcare market has been analyzed across the following segments:

 Type of Deployment
 Cloud
 Corporate Datacenter
 Hybrid
 On Premise

 Type of End User
 Life science / Biotechnology Companies
 Medical Device Providers
 Pharmaceutical Companies
 Others

 Key Geographical Regions
 North America
 Europe
 Asia
 Middle East and North Africa
 Latin America
 Rest of the World

The “Manufacturing Execution System Market, 2022-2035” report the following companies, which we identified to be key players in this domain:
 Andea
 Critical Manufacturing
 Dassault Systèmes
 GE Digital
 Infor
 Körber
 Rockwell Automation

Table of Contents

Background

Executive Summary

Introduction

Market Landscape

Key Insights

Partnerships and Collaborations

Company Competitiveness Analysis

Company Profiles

Value Creation Framework: A Strategic Guide to Address Unmet Need For Manufacturing Execution Systems

Market Forecast

Appendix I: Other Figures

Appendix II: Tabulated Data

Appendix III: List of Companies and Organizations


To view more details on this report, click on the link
https://www.rootsanalysis.com/....reports/manufacturin

You may also be interested in the following titles:
Global Antibiotics Market

Pharmaceutical Polymers / Medical Polymers Market


About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com


#manufacturingexecutionsystemsmarket #mes #manufacturingexecutionsystems #marketresearch #marketinsights

mRNA Synthesis and Manufacturing Services market 2022 – Industry Growth by 2035

The new market research report titled ‘MRNA Synthesis and Manufacturing Services Market’, published by Roots Analysis offers a comprehensive study of the MRNA Synthesis and Manufacturing Services industry. The report estimates the overall market size and the size and share of the key regional segments of the global market over historical period, as well as the projected timeline of 2023-2035.

The anticipated MRNA Synthesis and Manufacturing Services market growth is accredited to the significant surge in demand across the regional and global markets for the products and services offered by the MRNA Synthesis and Manufacturing Services industry. The latest study provides readers with a granular analysis of the major developmental elements of the global market, potential business avenues, and the overall market dynamics. The report has been specially curated to offer a deep understanding of the competitive terrain of the global market, highlighting the leading market rivals, their market positions, product portfolios, gross revenue shares, profit margins, pricing analysis, sales network & distribution channels, and financial standing.


Type of Product
• Drug Substances (APIs)
• Drug Products (FDFs)

Application Area(s)
• mRNA-based Vaccines
• mRNA-based Therapeutics

Therapeutic Area(s)
• Infectious Diseases
• Oncological Disorders
• Other Diseases

Key Geographical Regions
• North America
• Europe
• Asia-Pacific
• Latin America
• MENA
• Rest of the World

The latest research report specializes in the in-depth analysis of the macroeconomic and microeconomic factors affecting the MRNA Synthesis and Manufacturing Services market development. The report also concentrates on the regulatory framework that is shaping the future of the global market. New and existing pricing structures, emerging application areas, and upcoming investment opportunities have also been detailed in the report. The report further studies the projected growth factors that are expected to influence the market dynamics over the forecast timeframe.

The study is inclusive of a comprehensive analysis of the commonly used marketing and promotional strategies adopted by the key market players. Taking into account the existing market development factors, historical events, and recent market trends, the study presents a balanced opinion on the future scenario of the MRNA Synthesis and Manufacturing Services market. It thus supports its opinion by discussing the key corporate strategies, such as mergers & acquisitions, takeovers, joint ventures, and strategic alliances, used by the market players to strengthen their global footprint.

Research Methodology
Our analysts have performed an accurate examination of the various aspects of the global market leveraging avant-garde primary and secondary sources of data collection. The report has gathered the necessary data and information from several reliable sources. Additionally, the report offers many strategic recommendations for companies involved in this ever-growing business sector to help them attain a competitive edge in the mRNA Synthesis and mRNA Manufacturing Services market.

Thank you for reading our report. Kindly get in touch with us to know more about the report or to receive a customized copy of it. Our team will ensure the report is tailored according to your needs.

To view more details on this report, click on the link:
https://www.rootsanalysis.com/....reports/mrna-synthes

You may also be interested in the following titles:
Oral Solid Dosage Manufacturing Market

Lipid Nanoparticles in Drug Delivery


You may also like to learn what our experts are sharing in Roots educational series:
Is Blue Ocean Strategy The Silver Bullet For Emerging Teleradiology Players to Achieve A Breakthrough In This Highly Competitive Market?

CAR-T Cell Therapies: Addressing Key Unmet Needs Across Various Oncological Indications

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com

#mrnasynthesisandmanufacturingservicesmarket #mrnasynthesisandmanufacturingservicesmarketsize #mrnasynthesisservices #mrnasynthesisandmanufacturingservices #mrnabasedproducts

Investor Series: Opportunities in Artificial Intelligence in Drug Discovery market Analysis and Trends by 2022-2035

The new market report titled “Opportunities in the Artificial Intelligence in Drug Discovery Market”, published by Roots Analysis is one of the most sought-after solutions for investors operating in the Artificial Intelligence in Drug Discovery market.

The report will help investors stay updated with the latest market trends and opportunities associated with the Artificial Intelligence in Drug Discovery market. The report comes with a concise summary of the details regarding the historical market data, current market trends, future growth prospects, innovator and product landscape, company health indexing, value proposition analysis, company competitiveness, funding and investment, financial analysis of public ventures, business risk analysis, returns on investment and key acquisition targets, as well as the emerging market trends and opportunities in Artificial Intelligence in Drug Discovery market. The opportunities in the Artificial Intelligence in Drug Discovery market are anticipated to expand significantly.

However, the latest report is mainly intended for business leaders, experts, thought leaders, investors, start-ups and growth stage firms interested in Artificial Intelligence in Drug Discovery business space and is available in the form of PDF and spreadsheet.

Investor Series: Opportunities in the Artificial Intelligence in Drug Discovery Market:
Investor Series Scope and Market Size:
The report provides detailed information on the Artificial Intelligence in Drug Discovery market, covering the core and peripheral Artificial Intelligence in Drug Discovery solutions. It offers a technical and financial perspective on how the Artificial Intelligence in Drug Discovery market opportunities is likely to evolve, in terms of future business success, over the coming decade. The Artificial Intelligence in Drug Discovery market is broadly segmented on the basis of type of solution, type of therapy, therapeutic area and geographical regions. The segmental growth helps the investors, firms, business leaders to get a lucid picture of the niche pockets of growth, as well as the strategies deployed by the market players to drive the growth of these segments. This section of the report helps them understand and determine the core application areas and the differences between the target markets. The report scrutinizes the Artificial Intelligence in Drug Discovery market in terms of market size & volume and significant information pertaining to product bifurcation and Artificial Intelligence in Drug Discovery solutions overview.

Key Market Contenders:
This particular section of the Artificial Intelligence in Drug Discovery market report covers all the necessary details of the Artificial Intelligence in Drug Discovery’ solutions developed by players operating in the Artificial Intelligence in Drug Discovery market. The report goes on to elucidate a quantitative perspective on the relative health of the different innovator companies and an assessment of the various solutions, offered by the companies developing DTx solutions, featuring analysis based on number and types of products, and an informed perspective on the value of the offerings based on multiple relevant aspects.

Information on the funding and investment activity that has taken place in this domain since 2011 has also been included in this report. Moreover, the exhaustive report presents financing category-wise trends, describing the relative maturity of the innovator companies. Further, Artificial Intelligence in Drug Discovery market features a list of the leading Artificial Intelligence in Drug Discovery investors, based on their participation in financing activity in this industry segment. It also covers an elaborate review of the overall Artificial Intelligence in Drug Discovery market from a financial perspective, including detailed fundamental (insights from the balance sheet, and key financial ratios) and technical analyses (insights from historical and recent stock price variations, and analysis using popular stock performance indicators) of financial data of the publicly listed companies.

This section of Artificial Intelligence in Drug Discovery market report focusing on the competitive terrain of the Artificial Intelligence in Drug Discovery market endows the reader with every significant detail and information about the leading competitors on the market. The report provides a key acquisition targets analysis, highlighting some of the promising early-to-mid stage business ventures around which there is likely to be interest for future acquisitions / mergers and also includes the case study of instances where investors have exited various Artificial Intelligence in Drug Discovery related ventures, offering insights on return on investments made. Leveraging the abovementioned details, the report offers an informed opinion on the future outlook for investors in the Artificial Intelligence in Drug Discovery market.

Section covered in Artificial Intelligence in Drug Discovery market report:
Section 01: Need for Artificial Intelligence in Drug Discovery and Innovators Landscape
Section 02: Analysis of Investments
Section 03: Financial Analysis and Assessment of Business Risks
Section 04: Market Forecast and Opportunity Analysis
Section 05: Analysis of Returns on Investment and Key Acquisition Targets

To view more details on this report, click on the link:
https://www.rootsanalysis.com/....reports/ai-in-drug-d

You may also be interested in the following titles:
4D Bioprinting Market

Non-Viral / Intracellular Drug Delivery Systems Market


You may also like to learn what our experts are sharing in Roots educational series:
Smart pharmaceutical and healthcare labels: Lets trace medicines from its origin

Introduction To Exosome Therapeutics


About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com